1980
DOI: 10.1107/s0567740880009594
|View full text |Cite
|
Sign up to set email alerts
|

On the polymorphism of barbituric acid derivatives

Abstract: The barbituric acid derivative 5-ethyl-5-isopentylbarbituric acid (known as amobarbital or Amytal) has 0567-7408/80/112642-04501.00 two polymorphic forms in which the hydrogen-bond systems are identical but the space group is different. Another derivative, 5,5-diethylbarbituric acid (known as barbital or Veronal), has three polymorphs with

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

1981
1981
2018
2018

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 9 publications
0
8
0
Order By: Relevance
“…Many derivatives of barbituric acid also crystallize in various polymorphic forms. For example, barbital (5,5diethylbarbituric acid) was reported to form four polymorphs with crystal structures determined for three of them (Craven et al, 1969;Caillet & Claverie, 1980), whereas for violuric acid, a 5-substituted derivative of barbituric acid [pyrimidine-2,4,5,6-(1H,3H)-tetrone monohydrate], two polymorphic modifications were found: an orthorhombic one (Craven & Mascarenhas, 1964;Craven & Takei, 1964;Nichol & Clegg, 2005b) and a monoclinic one (Guille et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Many derivatives of barbituric acid also crystallize in various polymorphic forms. For example, barbital (5,5diethylbarbituric acid) was reported to form four polymorphs with crystal structures determined for three of them (Craven et al, 1969;Caillet & Claverie, 1980), whereas for violuric acid, a 5-substituted derivative of barbituric acid [pyrimidine-2,4,5,6-(1H,3H)-tetrone monohydrate], two polymorphic modifications were found: an orthorhombic one (Craven & Mascarenhas, 1964;Craven & Takei, 1964;Nichol & Clegg, 2005b) and a monoclinic one (Guille et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Polymorphism within the barbiturate family is widespread and well studied also in view of pharmaceutical interest. [35][36][37][38] The three crystal forms are easily prepared separately and could thus be used independently in the reaction with gases. A similar experiment has been carried out before by Stowell, Griesser, Byrn et al 39 in the course of the investigation of the reactivity of indomethacine amorphous and crystal forms with ammonia.…”
Section: Introductionmentioning
confidence: 99%
“…Barbituric acid is the parent molecule of the barbiturate family of drugs, which are of crystallographic interest not least for their propensity to form polymorphs. The 5,5-dialkyl derivatives are those which are pharmacologically active and which have been most extensively characterized by X-ray crystallography (Caillet & Claverie, 1980;Cleverley & Williams, 1959;Craven et al, , 1982, 1971McMullan et al, 1978;Nichol & Clegg, 2005a,b;Platteau et al, 2005;Sambyal et al, 1995;Williams, 1973Williams, , 1974. Contemporary research continues to focus on barbituric acid polymorphism as a model system for developing computational polymorph prediction techniques, something that is of major importance to the pharmaceutical industry (Lewis et al, 2004(Lewis et al, , 2005.…”
Section: Introductionmentioning
confidence: 99%